Senators want to clamp down on drugmakers’ patent protections

Published



Several Republican senators joined Democrats in calling for reining in a tool that drugmakers use to extend their monopolies.

Republicans and Democrats bashed the technique, called “evergreening,” during a hearing Tuesday on high drug prices in the Senate Health, Education, Labor and Pensions Committee.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.